Phost'in Therapeutics
1 known investors
Find your way into Phost'in Therapeutics
Phost'in Therapeutics is a Montpellier, France-based clinical-stage biopharmaceutical company developing small-molecule N-glycosylation modifiers, including GnT-V inhibitor PhOx430, to counter immune evasion in solid tumors and fibrotic diseases.
Investors · 1
Frequently asked questions
- What does Phost'in Therapeutics do?
- Phost'in Therapeutics is a Montpellier, France-based clinical-stage biopharmaceutical company developing small-molecule N-glycosylation modifiers, including GnT-V inhibitor PhOx430, to counter immune evasion in solid tumors and fibrotic diseases.
- Who are Phost'in Therapeutics's investors?
- Phost'in Therapeutics's investors include Remiges Ventures, Inc..